SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide

SU4312, initially designed as a multi-target tyrosine kinase inhibitor, is consequently reported to inhibit tumor angiogenesis by blocking VEGFR. However, although SU4312 can penetrate the brain–blood barrier, its potential to inhibit glioma growth is unknown. In this study, we report that SU4312 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Zhou, Yi, Wang, Yan, Wang, Xiang, Zhang, Yu, Mao, Yufei, Zhang, Long, Qi, Ji, Zhang, Yining, Lyu, Feng, Gu, Linbo, Yu, Rutong, Zhou, Xiuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410026/
https://www.ncbi.nlm.nih.gov/pubmed/36013004
http://dx.doi.org/10.3390/jcm11164765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410026/
https://www.ncbi.nlm.nih.gov/pubmed/36013004
http://dx.doi.org/10.3390/jcm11164765

Ejemplares similares